Management of irritable bowel syndrome in the patient with ulcerative colitis

Philip M. Ginsburg; Theodore M. Bayless

doi:10.1007/978-1-4939-1677-1_40

Management of irritable bowel syndrome in the patient with ulcerative colitis

Philip M. Ginsburg, Theodore M. Bayless

School of Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Irritable bowel syndrome (IBS) is one of the most common disorders in gastroenterology, affecting 10–15 % of the US population and accounting for one-quarter to one-half of all visits to digestive health specialists. With such a high prevalence, it may be inferred that a significant number of patients with ulcerative colitis (UC) also suffer from coexisting IBS. Indeed, it is widely believed that the prevalence of IBS is greater in patients with inflammatory bowel disease (IBD), affecting an estimated one-third of UC patients in remission. Recent research demonstrating a possible association between low-grade inflammation and IBS highlights the interconnecting relationship between inflammatory and functional disorders.

Original language	English (US)
Title of host publication	Medical Therapy of Ulcerative Colitis
Publisher	Springer New York
Pages	431-438
Number of pages	8
ISBN (Electronic)	9781493916771
ISBN (Print)	9781493916764
DOIs	https://doi.org/10.1007/978-1-4939-1677-1_40
State	Published - Jan 1 2014

Keywords

Diarrhea
IPAA
Inflammation
Irritable bowel syndrome
Prevalence
Proctosigmoiditis
Ulcerative colitis

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-1-4939-1677-1_40

Cite this

@inbook{f7facbe4c8d74ade9e3c0c1b3982851c,

title = "Management of irritable bowel syndrome in the patient with ulcerative colitis",

abstract = "Irritable bowel syndrome (IBS) is one of the most common disorders in gastroenterology, affecting 10–15 % of the US population and accounting for one-quarter to one-half of all visits to digestive health specialists. With such a high prevalence, it may be inferred that a significant number of patients with ulcerative colitis (UC) also suffer from coexisting IBS. Indeed, it is widely believed that the prevalence of IBS is greater in patients with inflammatory bowel disease (IBD), affecting an estimated one-third of UC patients in remission. Recent research demonstrating a possible association between low-grade inflammation and IBS highlights the interconnecting relationship between inflammatory and functional disorders.",

keywords = "Diarrhea, IPAA, Inflammation, Irritable bowel syndrome, Prevalence, Proctosigmoiditis, Ulcerative colitis",

author = "Ginsburg, {Philip M.} and Bayless, {Theodore M.}",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media New York 2014.",

year = "2014",

month = jan,

day = "1",

doi = "10.1007/978-1-4939-1677-1_40",

language = "English (US)",

isbn = "9781493916764",

pages = "431--438",

booktitle = "Medical Therapy of Ulcerative Colitis",

publisher = "Springer New York",

}

TY - CHAP

T1 - Management of irritable bowel syndrome in the patient with ulcerative colitis

AU - Ginsburg, Philip M.

AU - Bayless, Theodore M.

N1 - Publisher Copyright: © Springer Science+Business Media New York 2014.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Irritable bowel syndrome (IBS) is one of the most common disorders in gastroenterology, affecting 10–15 % of the US population and accounting for one-quarter to one-half of all visits to digestive health specialists. With such a high prevalence, it may be inferred that a significant number of patients with ulcerative colitis (UC) also suffer from coexisting IBS. Indeed, it is widely believed that the prevalence of IBS is greater in patients with inflammatory bowel disease (IBD), affecting an estimated one-third of UC patients in remission. Recent research demonstrating a possible association between low-grade inflammation and IBS highlights the interconnecting relationship between inflammatory and functional disorders.

AB - Irritable bowel syndrome (IBS) is one of the most common disorders in gastroenterology, affecting 10–15 % of the US population and accounting for one-quarter to one-half of all visits to digestive health specialists. With such a high prevalence, it may be inferred that a significant number of patients with ulcerative colitis (UC) also suffer from coexisting IBS. Indeed, it is widely believed that the prevalence of IBS is greater in patients with inflammatory bowel disease (IBD), affecting an estimated one-third of UC patients in remission. Recent research demonstrating a possible association between low-grade inflammation and IBS highlights the interconnecting relationship between inflammatory and functional disorders.

KW - Diarrhea

KW - IPAA

KW - Inflammation

KW - Irritable bowel syndrome

KW - Prevalence

KW - Proctosigmoiditis

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=84956806994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956806994&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-1677-1_40

DO - 10.1007/978-1-4939-1677-1_40

M3 - Chapter

AN - SCOPUS:84956806994

SN - 9781493916764

SP - 431

EP - 438

BT - Medical Therapy of Ulcerative Colitis

PB - Springer New York

ER -

Management of irritable bowel syndrome in the patient with ulcerative colitis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this